Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.
Opsonophagocytosis is a correlate of protection that measures the functional activity of vaccine-induced antibodies. A standardized opsonophagocytosis assay (OPA) should be used as part of the evaluation of current and future pneumococcal (Pnc) polysaccharide (Ps)-based vaccines. We enrolled five laboratories to evaluate a previously standardized viability OPA. Each laboratory was provided with a detailed OPA protocol, seven target Pnc strains (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F), two quality control sera and 12 paired sera (blinded) from adult donors who received one dose of the 23-valent Pnc Ps vaccine. Laboratories sent their results to the Centers for Disease Control and Prevention for analysis. Sera were tested in duplicate (single run), and the results were averaged to yield a single OPA titer (> or = 50% killing) for each serum sample. The percentage of sera within one or two dilutions of the calculated median OPA titer was determined for each laboratory and for each serotype. In general, laboratories were capable of detecting OPA titers within one or two dilutions of the median for at least 75 and 88%, respectively, of the sera tested. The level of agreement with the median OPA titers varied depending on the participating laboratory (overall agreement = 0.8 [99% confidence interval = 0.75 to 0.85]). All OPA median titers reported for quality control sera were within one dilution of the expected titer. We conclude that this OPA can be done in multiple laboratories with a high degree of interlaboratory reproducibility.
Romero-Steiner
Sandra
S
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. Ssteiner@cdc.gov
Frasch
Carl
C
Concepcion
Nelydia
N
Goldblatt
David
D
Käyhty
Helena
H
Väkeväinen
Merja
M
Laferriere
Craig
C
Wauters
Dominique
D
Nahm
Moon H
MH
Schinsky
Mark F
MF
Plikaytis
Brian D
BD
Carlone
George M
GM
D000328:Adult; D000906:Antibodies / Q000097:blood; D016022:Case-Control Studies; D002452:Cell Count; D002470:Cell Survival / Q000276:immunology*; D005260:Female; D018922:HL-60 Cells; D006801:Humans; D007118:Immunoassay / Q000592:standards*; D008297:Male; D015588:Observer Variation; D009895:Opsonin Proteins / Q000097:blood*; D010587:Phagocytosis; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012698:Serologic Tests; D013296:Streptococcus pneumoniae; D014612:Vaccines / Q000276:immunology
D000906:Antibodies; D009895:Opsonin Proteins; D011135:Polysaccharides, Bacterial; D014612:Vaccines